Fresenius Medical Care Files 6-K with Press Release
Ticker: FMCQF · Form: 6-K · Filed: Mar 5, 2024 · CIK: 1333141
| Field | Detail |
|---|---|
| Company | Fresenius Medical Care Ag (FMCQF) |
| Form Type | 6-K |
| Filed Date | Mar 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, press-release, filing
TL;DR
FMC dropped a 6-K with a press release on 3/5/24. Check Exhibit 99.1 for deets.
AI Summary
Fresenius Medical Care AG filed a Form 6-K on March 5, 2024, to report a press release issued on the same date. The press release, Exhibit 99.1, is the primary content of this filing. Helen Giza, CEO and Chair, signed the report.
Why It Matters
This filing indicates Fresenius Medical Care is disseminating important information to the public via a press release, which could contain updates on operations, financial performance, or strategic initiatives.
Risk Assessment
Risk Level: low — This filing is a routine submission of a press release and does not contain new financial data or significant corporate events that would inherently increase risk.
Key Players & Entities
- Fresenius Medical Care AG (company) — Registrant
- Helen Giza (person) — CEO and Chair
- March 5, 2024 (date) — Filing and Press Release Date
FAQ
What is the subject of the press release filed as Exhibit 99.1?
The filing does not specify the subject of the press release, only that it was issued on March 5, 2024, and is included as Exhibit 99.1.
Who signed the Form 6-K filing?
The Form 6-K was signed by Helen Giza, Chief Executive Officer and Chair of Fresenius Medical Care AG.
What is the Commission file number for Fresenius Medical Care AG?
The Commission file number for Fresenius Medical Care AG is 001-32749.
When was this Form 6-K filed?
This Form 6-K was filed on March 5, 2024.
Is Fresenius Medical Care AG required to file annual reports under Form 20-F?
The filing indicates that Fresenius Medical Care AG files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Filing Stats: 177 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-03-05 10:48:16
Filing Documents
- tm247990d1_6k.htm (6-K) — 10KB
- tm247990d1_ex99-1.htm (EX-99.1) — 11KB
- tm247990d1_ex99-1img001.jpg (GRAPHIC) — 4KB
- 0001104659-24-030835.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: March 5, 2024 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board